Sunil Healthcare declares AGM results; resolutions pass with 99% majority
- Sunil Healthcare declared AGM results on September 29, 2026
- Resolutions passed with 99.9963% majority in favour
- Total votes polled stood at 8,028,728 out of 10,254,750 shares
- Only 290 votes cast against both financial adoption and director re-appointment
*this image is generated using AI for illustrative purposes only.
Sunil Healthcare Ltd declared the results of its 52nd Annual General Meeting on September 29, 2026, confirming the passage of all proposed ordinary resolutions with a 99.9963% majority in favour.
The voting process, which included remote e-voting from September 25 to September 27 and Insta-poll during the meeting, saw 8,028,728 votes polled out of 10,254,750 outstanding shares. Promoter group members voted unanimously in favour, while public non-institutional shareholders recorded only 290 votes against across both agenda items.
Key resolutions passed
Shareholders approved two ordinary resolutions during the session held via video conferencing:
- Adoption of audited standalone and consolidated annual financial statements for FY26.
- Re-appointment of Sanjay Kumar Kaushik as Non-Executive Director, who retired by rotation.
Both resolutions were passed with requisite majority, with no abstentions or invalid votes recorded.
Management commentary on performance
Anil Kumar Khaitan, Chairman and Managing Director, addressed members regarding operational performance in FY26. He noted that despite challenges such as volatile raw material pricing, currency fluctuations, and subdued demand, the company improved its margins. These improvements were attributed to cost control measures that enhanced operational efficiency and profitability before exceptional items.
The management highlighted efforts to recalibrate demand and supply chains amidst inflationary pressures on input costs like raw materials and power. The Chairman stated that the company remains committed to improving production, sales, and profit through optimal product mix and exploring new avenues for growth.
Voting details and attendance
The meeting commenced at 12:30 pm and concluded at 12:46 pm on September 28, 2026. A total of 50 shareholders attended through video conferencing, comprising one promoter representative and 49 public shareholders. Remote e-voting was conducted by MUFG Intime India Pvt. Ltd., with ATCS & Associates serving as the scrutinizer.
| Metric | Resolution 1 (Financials) | Resolution 2 (Director Re-appt) |
|---|---|---|
| Votes Polled | 8,028,728 | 8,028,728 |
| Votes In Favour | 8,028,438 | 8,028,438 |
| Votes Against | 290 | 290 |
| % In Favour | 99.9963% | 99.9963% |
The results were declared by Satyendu Pattnaik, Company Secretary and Compliance Officer, as authorized by the Chairman.
Historical Stock Returns for Sunil Healthcare
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.89% | 0.0% | -7.68% | +2.64% | +2.64% | +2.64% |
How will Sunil Healthcare's continued focus on cost control and optimal product mix impact its gross margin trajectory in FY27 amidst persistent raw material volatility?
What specific new growth avenues or market expansions is management planning to pursue to offset the subdued demand noted in FY26?
Given the low shareholder attendance and minimal dissent, how might this high consensus influence future capital allocation decisions or potential dividend policy changes?
15
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
